Author

Zhiqian Wang

Chinese Academy of SciencesORCID 0000-0001-9831-649XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1

Frequent Co-Authors

Chengxiang XiaiD· 3 shared Dehao HuangiD· 3 shared Fangxiao HuiD· 3 shared Hanmeng Qi· 3 shared Jiaxin WuiD· 3 shared Jinyong WangiD· 3 shared Leqiang ZhangiD· 3 shared Mengyun ZhangiD· 3 shared

Activity by Year

2025-2025 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Chengxiang XiaORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyJournal for ImmunoTherapy of CancerPeer-reviewedSep 1, 2025

CD33KO-CD33-mesothelin loop CAR design avoids fratricide and improves efficacy of iNK cells against acute myeloid leukemia

Yao Wang, Xiujuan Zheng, Zhiqian Wang…·Jinyong Wang

This study designs a CD33-mesothelin loop CAR to enhance iNK cell efficacy against AML by avoiding fratricide and improving cytotoxicity.

6 citations

𝕏 PostBluesky

Cancer BiologyJournal of Hematology & OncologyPeer-reviewedMay 19, 2025

Engineered CRO-CD7 CAR-NK cells derived from pluripotent stem cells avoid fratricide and efficiently suppress human T-cell malignancies

Yunqing Lin, Ziyun Xiao, Fangxiao Hu…·Jinyong Wang

This study generates CD7 CAR-NK cells from pluripotent stem cells that avoid fratricide and effectively suppress T-cell malignancies in xenograft models.

16 citationstop 2%

humanexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJan 7, 2025

Pluripotent stem cell-derived NK progenitor cell therapy prevents tumour occurrence and eradicates minimal residual disease

Zhiqian Wang, Yunqing Lin, Dehao Huang…·Jinyong Wang

This study develops a novel CAR-NK cell therapy using pluripotent stem cell-derived NK progenitors that persist in blood and eliminate minimal residual disease.

2 citations

mouseexperimental assay

𝕏 PostBluesky